Isobutyric acid

Market Intelligence Report on Isobutyric Acid – Recent Commodity Market Dynamics

I. Price Trends
- Base Price: As of April 27, 2026, the ChemNet (Shengyishe) base price for isobutyric acid stood at RMB 8,900.00 per metric ton, down 5.32% from the beginning-of-month price of RMB 9,400.00/ton, and currently at a yearly low.
- Historical Volatility: From April 2025 to April 2026, the price of isobutyric acid reached a peak of RMB 11,100/ton and a trough of RMB 8,400/ton; the median value was RMB 9,750/ton. The current price is RMB 2,200/ton below the peak and RMB 500/ton above the trough.
- Regional Quotations:
Shandong Province: Spot supply price ranges from RMB 10,250–10,500/ton (minimum order: ≥1 ton); some suppliers quote RMB 9,000/ton for 99.5% purity grade.
Other Domestic Regions: Jinan Xinbo Chemical quotes RMB 13,500/ton (≥99% purity, packaged in 200 kg drums).
Imported Products: German-origin isobutyric acid imported directly is priced between RMB 6,000–12,000/ton, depending on supplier and purity specifications.

II. Supply-Demand Dynamics
- Supply Side:
Domestic production capacity is concentrated among leading enterprises: Jiangsu Hualun Chemical (15,000-ton/year high-optical-purity production line operating at full capacity), Zhejiang Royal Chemical (raw material supply secured via long-term agreement with Wanhua Chemical), and BASF (Nanjing Phase II plant—20,000 tons/year—scheduled to commence operations in Q2 2026).
Smaller manufacturers—including Anhui Tianchen Chemical and Hebei Chengxin Group—are constrained by environmental regulatory approvals and technological bottlenecks; their combined market share declined to 4.1% in 2025, down 0.9 percentage points year-on-year.
Import Dependence: Evonik imports German-produced isobutyric acid via its Shanghai trading company; import volume totaled 13,200 metric tons in 2025, accounting for 13.5% of domestic demand. However, implementation of the EU’s Carbon Border Adjustment Mechanism (CBAM) in 2026 is expected to reduce imports to 11,800 tons, lowering import share to 8.6%.
- Demand Side:
Agrochemical Intermediates: Accounted for 34.7% of total consumption in 2025, but growth slowed to 4.1% in 2026 due to China’s newly implemented “Maximum Residue Limits for Pesticides” standards.
Pharmaceutical CMO Sector: Benefiting from global order migration toward Chinese Contract Development and Manufacturing Organizations (CDMOs), isobutyric acid consumption in this sector is projected to grow by 15.6% YoY in 2026—emerging as the primary driver of demand growth.
New Energy Vehicle (NEV) Materials: BASF’s new capacity expansion specifically targets low-volatility isobutyric acid derivatives for automotive applications; its share in automotive adhesive formulations rose from 18.3% in 2025 to 25.6% in 2025.

III. Competitive Landscape
- Market Concentration: Industry CR5 (combined market share of top five players) is projected to rise to 86.3% in 2026, forming a “two-dominant, multiple-strong” structure:
Jiangsu Hualun Chemical: Its fully operational high-optical-purity production line elevated its market share to 30.1%.
BASF: Following commissioning of its Nanjing Phase II facility, sales volume surged to 31,500 tons, lifting its market share to 22.8%—surpassing Zhejiang Royal Chemical to become the second-largest supplier.
Zhejiang Royal Chemical: Capacity ramp-up delayed in 2026 due to safety-distance rectification requirements at its Shaoxing industrial park; market share edged down slightly to 20.9%.
- Technological Barriers: Leading firms have established differentiated advantages through GMP certification, international pharmaceutical regulatory registration support capabilities (e.g., BASF), and ultra-high optical purity products (e.g., Jiangsu Hualun’s 99.92% purity grade).

IV. Cost & Profitability
- Raw Material Costs: Zhejiang Royal Chemical signed a ten-year exclusive supply agreement with Wanhua Chemical for isobutyraldehyde, enabling a 5.8% YoY reduction in procurement costs in 2025—supporting stable end-product pricing.
- Gross Margins: Jiangsu Hualun Chemical’s high-optical-purity isobutyric acid—integrated into Active Pharmaceutical Ingredient (API) synthesis supply chains—achieves a gross margin of 48.7%, 22.4 percentage points higher than that of conventional industrial-grade products.

Analysis & Assessment
1. Downward Price Pressure: Current pricing reflects annual lows, driven primarily by increased supply (e.g., BASF Nanjing Phase II commissioning) and slowing demand growth (particularly in agrochemicals). Short-term price weakness and sideways consolidation are expected, though robust demand from the pharmaceutical sector may provide a floor.
2. Intensifying Structural Divergence: Demand remains strong for high-purity and specialty grades (e.g., optical-grade, pharma-grade). Leading enterprises reinforce competitive advantages through technological barriers and deep downstream integration. Smaller players unable to overcome environmental compliance or technical constraints face increasing risk of marginalization.
3. Accelerated Import Substitution: Expanding domestic capacity and improved product quality (e.g., Jiangsu Hualun Chemical, Zhejiang Royal Chemical), coupled with rising import costs (due to CBAM), are expected to further reduce import dependence in 2026.

Forward Outlook
1. Price Trend: During Q2–Q3 2026, prices may decline further to RMB 8,400–8,600/ton, reflecting both BASF Nanjing Phase II capacity release and seasonal softness in agrochemical demand. A rebound to RMB 9,000–9,200/ton is anticipated in Q4, supported by peak-season demand from the pharmaceutical sector.
2. Demand Structure: Pharmaceutical CMO demand share is expected to continue rising, potentially exceeding 20% by 2027—making it the largest end-use segment for isobutyric acid. Demand growth in NEV materials is forecast to remain steady at 10–15% annually.
3. Industry Consolidation: Over the next three years, industry CR5 is projected to exceed 90%. Smaller manufacturers will likely seek niche survival strategies—such as regional service specialization or development of customized or high-volatility product variants.